Antiviral action of methylated β-lactoglobulin on the human influenza virus a subtype H3N2

Probiotics and Antimicrobial Proteins

Volumn 2, Issue 2, 2010, Pages 104-111

  Sitohy, Mahmoud ^a,c   Besse, Bernard ^b   Billaudel, Sylviane ^b   Haertlé, Thomas ^a   Chobert, Jean Marc ^a  

^a INRA   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Zagazig University   (Egypt)

Author keywords

Antiviral activity; Beta lactoglobulin; Esterification; H3N2

Indexed keywords

BETA LACTOGLOBULIN; METHYLATED BETA LACTOGLOBULIN; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; HEMAGGLUTINATION; IC 50; IMMUNOFLUORESCENCE; INFLUENZA VIRUS A H3N2; NONHUMAN; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

HUMAN INFLUENZA VIRUS; INFLUENZAVIRUS A;

EID: 77953870541     PISSN: 18671306     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12602-010-9036-5     Document Type: Article

References (39)

1. Aoki FY, Boivin G, Roberts N (2007) Influenza virus susceptibility and resistance to oseltamivir. Antivir Ther 12: 603-616.
2. Barr IG, Hurt AC, Deed N, Iannello P, Tomasov C, Komadina N (2007) The emergence of adamantane resistance in influenza A (H1) viruses in Australia and regionally in 2006. Antivir Res 75: 173-176.
3. Baz M, Abed Y, McDonald J, Boivin G (2006) Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis 43: 1555-1561.
4. Bertrand-Harb C, Chobert J-M, Dufour E, Haertlé T (1991) Esterification of food proteins: characterization of the derivatives by a colorimetric method and by electrophoresis. Sci Aliments 11: 641-652.
5. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dilen PM, van der Noordaa J (1990) Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28: 495-503.
6. Boulo S, Akarsu H, Ruigrok RW, Baudin F (2007) Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes. Virus Res 124: 12-21.
7. Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI (2005) Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause of concern. Lancet 366: 1175-1181.
8. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI (2006) Adamantane resistance among influenza A viruses isolated during the 2005-2006 influenza season in the United States. JAMA 295: 891-894.
9. Cohen-Daniel L, Zakay-Rones Z, Resnick IB, Shapira MY, Dorozhko M, Mador N, Greenbaum E, Wolf DG (2009) Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient. J Clin Virol 44: 138-140.
10. de Clerq E (2006) Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 5: 1015-1025.
11. Donald HB, Isaacs A (1954) Counts of influenza virus particles. J Gen Microbiol 10: 457-464.
12. Glaser L, Stevens J, Zamarin D, Wilson IA, García-Sastre A, Tumpey TM, Basler CF, Taubenberger JK, Palese P (2005) A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol 79: 11533-11536.
13. Gubareva LV, Robinson MJ, Bethell RC, Webster RG (1997) Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en. J Virol 71: 3385-3390.
14. Halpin MI, Richardson T (1985) Selected functionality changes of β-lactoglobulin upon esterification of side-chain carboxyl groups. J Dairy Sci 68: 3189-3198.
15. Horimoto T, Kawaoka Y (2005) Influenza: lessons from past pandemics, warning from current incidents. Nat Rev Microbiol 3: 591-600.
16. Huang T-S, Palese P, Krystal M (1990) Determination of influenza virus proteins required for genomic replication. J Virol 64: 5669-5673.
17. Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG (2006) Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis 193: 760-764.
18. Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y (2004) Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364: 759-765.
19. Leyssen P, de Clercq E, Neyts J (2008) Molecular strategies to inhibit the replication of RNA viruses. Antivir Res 78: 9-25.
20. Mailliart P, Ribadeau Dumas B (1988) Preparation of β-lactoglobulin and α-lactoglobulin-free proteins from whey retentate by sodium chloride salting out at low pH. J Food Sci 53: 743-752.
21. Morris SJ, Nightingale K, Smith H, Sweet C (2005) Influenza A virus induced apoptosis is a multifactorial process: exploiting reverse genetics to elucidate the role of influenza A virus proteins in virus induced apoptosis. Virology 335: 198-211.
22. Murayama R, Harada Y, Shibata T, Kuroda K, Hayakawa S, Shimizu K, Tanaka T (2007) Influenza A virus non-structural protein 1 (NS1) interacts with cellular multifunctional nucleolin during infection. Biochem Biophys Res Commun 362: 880-885.
23. Nichols WG, Guthrie KA, Corey L, Boeckh M (2004) Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 39: 1300-1306.
24. Oliveira JCR, Montes de Oca H, Duarte MM, Diniz CR, Fortes-Dias CL (2002) Toxicity of South American snake venoms measured by an in vitro cell culture assay. Toxicon 40: 321-325.
25. Poole E, Elton D, Medcalf L, Digard P (2004) Functional domains of influenza A virus PB2 protein: identification of NP- and PB1-binding sites. Virology 321: 120-133.
26. Rachakonda PS, Veit M, Korte T, Ludwig K, Bottcher C, Huang Q, Schmidt MFG, Herrmann A (2007) The relevance for the stability of the influenza virus hemagglutinin. FASEB J 21: 995-1002.
27. Seidel W, Künkel F, Geisler B, Garten W, Herrmann B, Döhner L, Klenk HD (1991) Intra epidemic variants of influenza virus H3 hemagglutinin differing in the number of carbohydrate side chains. Arch Virol 120: 289-296.
28. Sitohy M, Billaudel S, Haertlé T, Chobert J-M (2007) Antiviral activity of esterified α-lactalbumin and β-lactoglobulin against herpes simplex virus type 1. Comparison with the effect of acyclovir and l-polylysines. J Agric Food Chem 55: 10214-10220.
29. Sitohy M, Chobert J-M, Dalgalarrondo M, Nowoczin M, Besse B, Billaudel S, Haertlé T (2008) The effect of bovine whey proteins on the ability of Poliovirus and Coxsackie virus to infect Vero cells cultures. Int Dairy J 18: 658-668.
30. Sitohy M, Chobert J-M, Haertlé T (2001) Simplified short-time method for the esterification of milk proteins. Milchwissenschaft 56: 127-131.
31. Sitohy M, Chobert J-M, Haertlé T (2005) Esterified whey proteins can protect Lactococcus lactis against bacteriophage infection. Comparison with the effect of native basic proteins and l-polylysines. J Agric Food Chem 53: 3727-3734.
32. Sitohy M, Chobert J-M, Karwowska U, Gozdzicka-Jozefiak A, Haertlé T (2006) Inhibition of bacteriophage M13 replication with esterified milk proteins. J Agric Food Chem 54: 3800-3806.
33. Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, Perdue ML, Daum Lohman K, LT Suaez DL (2002) Development of a real-time reverse transcriptase PCR assay for Type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 40: 3256-3260.
34. Stevens J, Blixt O, Glaser L, Taubenberger JK, Palese P, Paulson JC, Wilson IA (2006) Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 355: 1143-1155.
35. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA (2006) Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312: 404-410.
36. Sun L, Zhang G, Shu Y, Chen X, Zhu Y, Yang L, Ma G, Kitamura Y, Liu W (2009) Genetic correlation between H3N2 human and swine influenza viruses. J Clin Virol 44: 141-144.
37. Vigerust DJ, Shepherd VL (2007) Virus glycosylation: role in virulence and immune interactions. Trends Microbiol 15: 211-218.
38. Vigerust DJ, Ulett KB, Boyd KL, Madsen J, Hawgood S, McCullers JA (2007) N-Linked glycosylation attenuates H3N2 influenza viruses. J Virol 81: 8593-8600.
39. Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody binding sites of Hong Kong influenza hemagglutinin and their involvement in antigenic variation. Nature 289: 373-378.